Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ingenol mebutate gel 0.015% with diclofenac sodium gel 3% for actinic keratoses on the face or scalp, evaluating efficacy and safety; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac Sodium Gel 3% (diclofenac sodium gel 3%)
• Ingenol Mebutate Gel, 0.015% (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis (AK) | Phase 4 | Status: COMPLETED